Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm

被引:92
作者
Mulsant, BH
Alexopoulos, GS
Reynolds, CF
Katz, IR
Abrams, R
Oslin, D
Schulberg, HC
机构
[1] Univ Pittsburgh, Sch Med, Intervent Res Ctr Study Late Life Mood Disorders, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA
[3] Pittsburgh Vet Adm Hlth Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA
[4] Cornell Univ, Weill Med Coll, Intervent Res Ctr Geriatr Mood Disorders, White Plains, NY 10605 USA
[5] Cornell Univ, Weill Med Coll, Dept Psychiat, White Plains, NY 10605 USA
[6] Univ Penn, Intervent Res Ctr Depress Late Life, Philadelphia, PA 19104 USA
[7] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
关键词
geriatric depression; primary care; treatment; pharmacology; pharmacotherapy; antidepressant; psychotherapy;
D O I
10.1002/gps.465
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
PROSPECT (Prevention of Suicide in Primary care Elderly-Collaborative Trial) is testing whether a trained clinician (the 'health specialist') can work in close collaboration with a primary care physician to implement a comprehensive depression management program and improve outcomes in older depressed patients. An algorithm guiding the selection and use of antidepressant medications has been developed to assist PROSPECT health specialists. This algorithm is presented and the rationale underlying the proposed treatment sequence is discussed. The PROSPECT algorithm builds upon existing guidelines after updating them and adapting them to the special circumstances of older primary care patients. Special attention has been paid to the tolerability and the target doses of the recommended antidepressant agents and to the duration of antidepressant trials. Patients who are unable to tolerate or do not respond to an antidepressant can be switched to another agent or be treated with interpersonal psychotherapy. Agents that produce only a partial response can be combined with other antidepressants or with interpersonal psychotherapy. Treatments for which empirical evidence exists are favored. However, treatments that are often poorly tolerated by elderly patients: are given lower priority than treatments more likely to be tolerated. Similarly, trials that are simpler to implement in primary care are favored. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:585 / 592
页数:8
相关论文
共 49 条
[1]   Treatment algorithms in treatment-resistant depression [J].
Amsterdam, JD ;
HornigRohan, M .
PSYCHIATRIC CLINICS OF NORTH AMERICA, 1996, 19 (02) :371-+
[2]  
[Anonymous], 1993, AM J PSYCHIAT, V150, P1
[3]  
[Anonymous], BRIT J CLIN RES
[4]  
Bonner D, 1995, Int Psychogeriatr, V7 Suppl, P83, DOI 10.1017/S1041610295002377
[6]  
Bruce M L, 1999, Dialogues Clin Neurosci, V1, P100
[7]   The recognition and treatment of late-life depression: A view from primary care [J].
Callahan, CM ;
Hendrie, HC ;
Tierney, WM .
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 1996, 26 (02) :155-171
[8]  
COHN CK, 1990, J CLIN PSYCHIAT, V51, P28
[9]   Venlafaxine in treatment-resistant major depression: A Canadian multicenter, open-label trial [J].
de Montigny, C ;
Silverstone, PH ;
Debonnel, G ;
Blier, P ;
Bakish, D .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (05) :401-406
[10]  
*DEPR GUID PAN, 1993, CLIN PRACT GUID, V5